Welcome to visit Zhongnan Medical Journal Press Series journal website!

Home Articles Vol 34,2025 No.4 Detail

Effect of dexmedetomidine on the median effective concentration of ropivacaine during sciatic nerve block combined with femoral nerve block in patients undergoing lower extremity surgery

Published on Apr. 27, 2025Total Views: 43 times Total Downloads: 10 times Download Mobile

Author: CHEN Zuquan 1 GU Xiaoping 2 ZOU Wenjun 3 HE Fuqiang 1

Affiliation: 1. Department of Anesthesiology, the Fourth People's Hospital of Sichuan Province, Chengdu 610000, China 2. Department of Anesthesiology, Western Theater Command General Hospital of Chinese People's Liberation Army, Chengdu 610000, China 3. Department of Anesthesiology, West China Chunxi Hospital, Sichuan University, Chengdu 610000, China

Keywords: Dexmedetomidine Ropivacaine Sciatic nerve block Femoral nerve block Median effective concentration

DOI: 10.12173/j.issn.1005-0698.202410098

Reference: CHEN Zuquan, GU Xiaoping, ZOU Wenjun, HE Fuqiang. Effect of dexmedetomidine on the median effective concentration of ropivacaine during sciatic nerve block combined with femoral nerve block in patients undergoing lower extremity surgery[J]. Yaowu Liuxingbingxue Zazhi, 2025, 34(4): 380-390. DOI: 10.12173/j.issn.1005-0698.202410098.[Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

Objective  To investigate the effect of dexmedetomidine on the median effect concentration (EC50) of ropivacaine during sciatic nerve block combined with femoral nerve block in patients undergoing lower extremity surgery.

Methods  Patients with sciatic nerve block combined with femoral nerve block anesthesia who underwent lower extremity surgery from November 2021 to November 2023 were selected as the study objects. They were randomly divided into control group (0.9% saline), group D1 (0.50 μg·kg-1 dexmedetomidine), group D2 (0.75 μg·kg-1 dexmedetomidine) and group D3 (1.00  μg·kg-1 dexmedetomidine). The stress response, serum pain mediators, vital signs and visual analogue scale (VAS) of patients at different time points during operation were analyzed by repeated measures ANOVA. ropivacaine EC50 was measured by sequential method, and the relationship between dexmedetomidine dose and ropivacaine EC50 was analyzed by Logistic regression.

Results  A total of 208 patients were include and each group was 52 patients. Compared with the same group before surgery, the stress response level of the 4 groups after surgery and 1 h after surgery was significantly decreased, and the serum pain mediators level was significantly increased (P<0.05). Compared with the control group, the stress response and serum pain mediators levels in groups D1, D2 and D3 were more normal after surgery and 1 h after surgery, among them, group D3 was most close to the normal value (P<0.05). There were no significant differences in blood oxygen saturation and bifrequency index of EEG among the four groups at each time point (P>0.05). At T1 and T2, the heart rate (HR) of the control group was significantly higher than that of the group D2 and D3 (P<0.05). At T1, the control group had a significantly higher mean arterial pressure (MAP) than the other three groups, at T2, the control group had a significantly higher MAP than the group D2 and D3, and at T3, the control group had a significantly higher MAP than the group D3 (P<0.05). VAS scores in 4 groups were significantly lower after surgery and 1 h after surgery than before surgery (P<0.05). The VAS score in group D3 was significantly lower than that in group D1 and D2 (P<0.05). Repeated measurement ANOVA showed that the effects of time on stress response and serum pain mediators were different with different anesthesia methods. The influence of time on HR, MAP and VAS scores varied with different anesthesia methods. Sequential assay results showed that the EC50 of ropivacaine in control group, group D1, group D2 and group D3 was 5.985, 5.631, 5.329 and 5.125 μg·mL-1, respectively. Logistic results showed that the dose of dexmedetomide was a protective factor for ropivacaine EC50 in sciatic nerve block combined with femoral nerve block in limb surgery patients (P<0.05).

Conclusion  The ropivacaine EC50 can be significantly reduced by 1.00 μg·kg-1 dexmedetomidine. This is a protective factor for sciatic nerve block combined with femoral nerve block in patients undergoing lower limb surgery, and it can be applied clinically.

Full-text
Please download the PDF version to read the full text: download
References

1.Reysner M, Reysner T, Janusz P, et al. Dexamethasone as a perineural adjuvant to a ropivacaine popliteal sciatic nerve block for pediatric foot surgery: a randomized, double-blind, placebo-controlled trial[J]. Reg Anesth Pain Med, 2024: rapm-2024-105694. DOI: 10.1136/rapm-2024-105694.

2.Nair R, Samra T, Ashok V, et al. Efficacy of ultrasound-guided classical versus parasacral parallel shift technique of sacral plexus block for lower limb surgeries - a randomised controlled trial[J]. Indian J Anaesth, 2024, 68(8): 712-717. DOI: 10.4103/ija.ija_36_24.

3.Mohamed FK, Ahmed AAM, El-Baz AA, et al. Harnessing the therapeutic potential of bone marrow-derived stem cells for sciatic nerve regeneration in diabetic neuropathy[J]. Tissue Cell, 2024, 91: 102543. DOI: 10.1016/j.tice.2024.102543.

4.Ahuja V, Samanta S. Role of lumbar sympathetic block in management of iatrogenic sciatic nerve palsy[J]. Trop Doct, 2024, 54(4): 372-373. DOI: 10.1177/00494755241265390.

5.Ma P, Zeng R, Peng J, et al. The median effective concentration of ropivacaine for ultrasound-guided anterior iliopsoas muscle space block in the elderly undergoing hip surgery: a dose-finding study[J]. Peer J, 2024, 12: e17970. DOI: 10.7717/peerj.17970.

6.Yang Z, Xu W, Xu S. Comparison of the efficacy and safety of different puncture routes for ultrasound-guided fascia iliaca compartment block for early analgesia after hip arthroplasty: a Meta-analysis[J]. Medicine (Baltimore), 2024, 103(35): e39313. DOI: 10.1097/MD.0000000000039313.

7.Thomas B, Barclay G, Lo WA, et al. Dexmedetomidine versus midazolam for end-of-life sedation and agitation: protocol for a randomized controlled trial (the dreams trial)[J]. JMIR Res Protoc, 2024, 13: e55129. DOI: 10.2196/55129.

8.Mu T, Yuan B, Wei K, et al. Adductor canal block combined with genicular nerve block versus local infiltration analgesia for total knee arthroplasty: a randomized noninferiority trial[J]. J Orthop Surg Res, 2024, 19(1): 546. DOI: 10.1186/s13018-024-05048-5.

9.罗晶, 刘轶, 熊艳. 臂丛颈丛神经阻滞麻醉联合瑞芬太尼在锁骨骨折中的应用及对OAA/S评分、VAS评分的影响[J]. 吉林医学, 2024, 45(5): 1133-1136. [Luo J, Liu Y, Xiong Y. Application of brachial plexus cervical plexus block anesthesia combined with remifentanil in the treatment of clavicle fracture and its effect on OAA/S score and VAS score[J]. Jilin Medical Science, 2024, 45(5): 1133-1136.] DOI: 10.3969/j.issn.1004-0412.2024.05.035.

10.钱真真, 武红莉, 于亚南, 等. 药物临床试验中常见医学统计学概念及样本量估算[J]. 中国医药导报, 2023, 20(32): 164-167. [Qian ZZ, Wu HL, Yu YN, et al. Common medical statistics concepts and sample size estimation in drug clinical trials[J]. China Medical Review, 2023, 20(32): 164-167.] DOI: 10.20047/j.issn1673-7210.2023.32.36.

11.Shao X, Ma X, Chen F, et al. A random parameters ordered probit analysis of injury severity in truck involved rear-end collisions[J]. Int J Environ Res Public Health, 2020, 17(2): 395. DOI: 10.3390/ijerph17020395.

12.Raj P, Sinha N, Kharwar RK, et al. Effects of local wound infiltration post-mastectomy using bupivacaine alone, bupivacaine with ketamine, and bupivacaine with dexmedetomidine: a randomized double-blind study[J]. Cureus, 2024, 16(7): e65727. DOI: 10.7759/cureus.65727.

13.陈雨辰, 杨晓宇, 王佳. 不同剂量右美托咪定复合丙泊酚在老年肺结核支气管镜检查中的效果观察[J]. 中国现代医学杂志, 2024, 34(9): 15-21. [Chen YC, Yang XY, Wang J. Effect of dexmedetomidine combined with propofol in bronchoscopy of senile pulmonary tuberculosis[J]. Chinese Journal of Modern Medicine, 2024, 34(9): 15-21.] DOI: 10.3969/j.issn.1005-8982.2024.09.003.

14.Yadav T, Kumar M, Verma K. Comparison of intravenous dexmedetomidine versus dexmedetomidine-dexamethasone combination for preventing postoperative nausea and vomiting in adult patients after abdominal surgeries[J]. Cureus, 2024, 16(7): e65913. DOI: 10.7759/cureus.65913.

15.Bu HM, Zhao M, Ma HM, et al. Application value of dexmedetomidine in anesthesia for elderly patients undergoing radical colon cancer surgery[J]. World J Gastrointest Surg, 2024, 16(8): 2671-2678. DOI: 10.4240/wjgs.v16.i8.2671.

16.Sharma R, Bhutda S, Bhutda S, et al. Role of dexmedetomidine and clonidine with hyperbaric ropivacaine in subarachnoid block: a comprehensive review[J]. Cureus, 2024, 16(7): e65798. DOI: 10.7759/cureus.65798.

17.崔琦芬, 汤士亚, 陆晓刚, 等. 右美托咪定复合罗哌卡因腹横肌平面阻滞的应用进展[J]. 武警医学, 2021, 32(3): 259-261. [Cui QF, Tang SY, Lu XG, et al. Progress in the application of dexmedetomidine combined with ropivacaine in transverse abdominal muscle plane block[J]. Chinese Journal of Armed Police Medicine, 2021, 32(3): 259-261.] DOI: 10.3969/j.issn.1004-3594.2021.03.022.

18.张芮, 王志涛, 刘德君, 等. 不同剂量右美托咪定对瑞马唑仑致患者意识消失ED95及应激反应的影响[J]. 实用医学杂志, 2023, 39(4): 476-480. [Zhang R, Wang ZT, Liu DJ, et al. Effect of dexmedetomidine on unconsciousness ED95 and stress response induced by remazolam[J]. Journal of Practical Medicine, 2023, 39(4): 476-480.] DOI: 10.3969/j.issn.1006-5725.2023.04.016.

19.Nakamura T, Iwasaki H, Miyazawa H, et al. Usefulness of deep sedation with intravenous dexmedetomidine and midazolam in cardiac catheterization procedures for pediatric patients[J]. Front Pediatr, 2024, 12: 1338130. DOI: 10.3389/fped.2024.1338130.

20.李丹, 易帅, 张鑫磊, 等. 瑞马唑仑和右美托咪定对甲状腺手术全麻苏醒期呛咳抑制效果的比较[J]. 药物流行病学杂志, 2024, 33(4): 402-409. [Li D, Yi S, Zhang XL, et al. Comparative effect of remazolam and dexmedetomidine on cough suppression during recovery period of thyroid operation under general anesthesia[J]. Journal of Pharmacoepidemiology, 2024, 33(4): 402-409.] DOI: 10.12173/j.issn.1005-0698.202401052.

21.Kumari KS, Thippeswamy HG, Nayak SR, et al. Addition of dexmedetomidine to propofol anesthesia for middle-ear surgeries: a prospective randomized double-blind study[J]. Cureus, 2024, 16(8): e68025. DOI: 10.7759/cureus.68025.

Popular papers
Last 6 months